Related Experiment Video
Updated: Apr 18, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma
Bilal N Sheikh1, Stanley C W Lee1, Farrah El-Saafin1
1The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia; and Department of Medical Biology, and.
Abstract:
The histone acetyltransferase MOZ (MYST3, KAT6A) is the target of recurrent chromosomal translocations fusing the MOZ gene to CBP, p300, NCOA3, or TIF2 in particularly aggressive cases of acute myeloid leukemia. In this study, we report the role of wild-type MOZ in regulating B-cell progenitor proliferation and hematopoietic malignancy. In the Eμ-Myc model of aggressive pre-B/B-cell lymphoma, the loss of just one allele of Moz increased the median survival of mice by 3.9-fold. MOZ was required to maintain the proliferative capacity of B-cell progenitors, even in the presence of c-MYC overexpression, by directly maintaining the transcriptional activity of genes required for normal B-cell development. Hence, B-cell progenitor numbers were significantly reduced in Moz haploinsufficient animals. Interestingly, we find a significant overlap in genes regulated by MOZ, mixed lineage leukemia 1, and mixed lineage leukemia 1 cofactor menin. This includes Meis1, a TALE class homeobox transcription factor required for B-cell development, characteristically upregulated as a result of MLL1 translocations in leukemia. We demonstrate that MOZ localizes to the Meis1 locus in pre-B-cells and maintains Meis1 expression. Our results suggest that even partial inhibition of MOZ may reduce the proliferative capacity of MEIS1, and HOX-driven lymphoma and leukemia cells.
Insights
Wild-type MOZ protein is crucial for B-cell progenitor proliferation and hematopoietic malignancy. Inhibiting MOZ may reduce the proliferative capacity of MEIS1 and HOX-driven lymphoma and leukemia cells.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- The histone acetyltransferase MOZ (MYST3, KAT6A) is implicated in aggressive acute myeloid leukemia due to chromosomal translocations.
- Wild-type MOZ's role in normal B-cell development and its potential contribution to hematopoietic malignancies remain under investigation.
Purpose of the Study:
- To investigate the function of wild-type MOZ in regulating B-cell progenitor proliferation.
- To determine MOZ's role in hematopoietic malignancy, specifically in the context of B-cell lymphoma.
Main Methods:
- Utilized the Eμ-Myc mouse model of aggressive pre-B/B-cell lymphoma.
- Assessed the impact of Moz haploinsufficiency on mouse survival and B-cell progenitor proliferation.
- Analyzed gene expression overlap between MOZ, MLL1, and menin, focusing on Meis1 regulation.
Main Results:
- Loss of one Moz allele significantly increased median survival in the Eμ-Myc lymphoma model (3.9-fold).
- MOZ is essential for maintaining B-cell progenitor proliferative capacity, even with c-MYC overexpression.
- B-cell progenitor numbers were reduced in Moz haploinsufficient animals.
- MOZ directly maintains the expression of genes vital for normal B-cell development, including Meis1.
- MOZ was found to localize to the Meis1 locus and maintain its expression in pre-B cells.
Conclusions:
- Wild-type MOZ plays a critical role in maintaining B-cell progenitor proliferation and is involved in hematopoietic malignancy.
- MOZ's regulation of Meis1 expression is a key mechanism underlying its function in B-cell development and potentially in leukemogenesis.
- Partial inhibition of MOZ could be a therapeutic strategy against MEIS1 and HOX-driven lymphoma and leukemia.
Related Concept Videos
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Hematopoietic Stem Cells
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

